Global Transcatheter Treatment Device Market 2022 - Snapshot

September 2022 | 33 pages | ID: G6DCF0FD813FEN
Gen Consulting Company

Abstracts

The global transcatheter treatment device market is anticipated to increase by USD 12 billion till 2028 at an average annual growth of 14.3 percent as per the latest report by Gen Consulting Company.

This industry report offers market estimates of the global market, followed by a detailed analysis of the product, procedure approach, valve type, and region. The global market data on transcatheter treatment device can be segmented by product: transcatheter aortic valve repair and replacement devices (TAVR/TAVI), transcatheter mitral valve repair (TMVR) devices, transcatheter tricuspid valve repair (TTVR) devices. According to the research, the transcatheter aortic valve repair and replacement devices (TAVR/TAVI) segment had the largest share in the global transcatheter treatment device market. Transcatheter treatment device market is further segmented by procedure approach: transfemoral, transapical, transaortic. In 2021, the transfemoral segment made up the largest share of revenue generated by the transcatheter treatment device market. Based on valve type, the transcatheter treatment device market is segmented into: balloon-expanded valves, self-expanded valves. Among these, the self-expanded valves segment was accounted for the highest revenue generator in 2021. On the basis of region, the transcatheter treatment device market also can be divided into: Asia Pacific, Europe, North America, Rest of the World (RoW). North America captured the largest share of the market in 2021.

The global transcatheter treatment device market is highly competitive. The key players in the transcatheter treatment device market include Abbott Laboratories, Biosensors International Group Ltd., Biotronik SE & Co. KG., Boston Scientific Corporation, Bracco S.p.A., Edwards Lifesciences Corporation, Medtronic plc, Neovasc Inc.

The data-centric report focuses on market trends, status and outlook for segments. With comprehensive market assessment across the major geographies, the report is a valuable asset for the existing players, new entrants and the future investors.

Why buy this report?

• Get a detailed picture of the Global Transcatheter Treatment Device Market
• Identify segments/areas to invest in over the forecast period in the Global Transcatheter Treatment Device Market
• Understand the competitive environment, the market’s leading players
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. SUMMARY

PART 2. INTRODUCTION

Study period
Geographical scope
Market segmentation

PART 3. TRANSCATHETER TREATMENT DEVICE MARKET OVERVIEW

PART 4. MARKET BREAKDOWN BY PRODUCT

Transcatheter aortic valve repair and replacement devices (TAVR/TAVI)
Transcatheter mitral valve repair (TMVR) devices
Transcatheter tricuspid valve repair (TTVR) devices

PART 5. MARKET BREAKDOWN BY PROCEDURE APPROACH

Transfemoral
Transapical
Transaortic

PART 6. MARKET BREAKDOWN BY VALVE TYPE

Balloon-expanded valves
Self-expanded valves

PART 7. MARKET BREAKDOWN BY REGION

Asia Pacific
Europe
North America
Rest of the World (RoW)

PART 8. KEY COMPANIES

Abbott Laboratories
Biosensors International Group, Ltd.
Biotronik SE & Co. KG.
Boston Scientific Corporation
Bracco S.p.A.
Edwards Lifesciences Corporation
Medtronic plc
Neovasc Inc.

PART 9. METHODOLOGY